Sponsor pipeline

Intellia Therapeutics clinical trial pipeline

6 active trials 2 recruiting 3 Phase 3 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-04

Trial status changed: Recruiting → Enrolling by Invitation

NCT05697861 Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

Phase 1/2		1
Phase 3		3

Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT06672237	A Phase 3 Study of NTLA-2001 in ATTRv-PN	Neuromuscular Disease	Recruiting	2026-04-16
NCT06128629	MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis…	Transthyretin Amyloidosis (ATTR) With Cardiomyopathy	Recruiting	2026-03-27
NCT06634420	HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema…	Hereditary Angioedema	Active, Not Recruiting	2026-07-29
Phase 1/2
NCT05120830	NTLA-2002 in Adults With Hereditary Angioedema (HAE)	Hereditary Angioedema	Active, Not Recruiting	2026-03-24
Not specified
NCT05697861	Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001	Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy	Enrolling by Invitation	2026-08-03
NCT06262399	Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002	Hereditary Angioedema	Enrolling by Invitation	2025-11-28